Persistence of the prognostic importance of left ventricular systolic function and heart failure after myocardial infarction: 17‐year follow‐up of the TRACE register

Left ventricular systolic function and presence of heart failure (HF) are important prognostic factors and dictate future therapeutic strategies after myocardial infarction (MI). We evaluated persistence of the prognostic importance of left ventricular dysfunction and HF in consecutive MI patients screened for entry in the Trandolopril Cardiac Evaluation Registry (TRACE) study.

[1]  L. Køber,et al.  Influence of age on the prognostic importance of left ventricular dysfunction and congestive heart failure on long-term survival after acute myocardial infarction. TRACE Study Group. , 1996, American Journal of Cardiology.

[2]  L. Køber,et al.  Prognostic importance of systolic and diastolic function after acute myocardial infarction. , 2003, American heart journal.

[3]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[4]  C. Frampton,et al.  B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction , 2003, Circulation.

[5]  E. Toft,et al.  Prognostic usefulness of repeated echocardiographic evaluation after acute myocardial infarction. TRACE Study Group. TRAndolapril Cardiac Evaluation. , 1999, The American journal of cardiology.

[6]  Marc A Pfeffer,et al.  Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  C. Viscoli,et al.  Differences between women and men in survival after myocardial infarction. Biology or methodology? , 1990, JAMA.

[8]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[9]  A. Camm,et al.  Changes in absolute and relative importance in the prognostic value of left ventricular systolic function and congestive heart failure after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. , 1998, The American journal of cardiology.

[10]  J. Herlitz,et al.  Characteristics and prognosis of patients with acute myocardial infarction in relation to occurrence of congestive heart failure. , 1994, European heart journal.

[11]  E. Gilpin,et al.  Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. , 1988, The American journal of cardiology.

[12]  L. Køber,et al.  An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. , 1994, European heart journal.

[13]  M. Nieminen,et al.  [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. , 2004, Revista espanola de cardiologia.

[14]  A. Weyman,et al.  Cross-sectional Echocardiographic Analysis of the Extent of Left Ventricular Asynergy in Acute Myocardial Infarction , 1980, Circulation.

[15]  L. Køber,et al.  Influence of gender on short- and long-term mortality after acute myocardial infarction. TRACE study group. , 1996, The American journal of cardiology.

[16]  J. Gore,et al.  Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. , 2006, American heart journal.

[17]  L. Køber,et al.  Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. , 1995, The American journal of cardiology.

[18]  A. Camm,et al.  Importance of congestive heart failure and interaction of congestive heart failure and left ventricular systolic function on prognosis in patients with acute myocardial infarction. , 1996, The American journal of cardiology.

[19]  E. Aliot,et al.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. , 1995, The New England journal of medicine.

[20]  J. Berning,et al.  Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. , 1990, The American journal of cardiology.

[21]  L. Køber.  Importance of Congestive Heart Failure and Interaction of Congestive Heart Failure and Left Ventricular Systolic Function on Prognosis in Patients With Acute Myocardial Infarction , 1996 .

[22]  T. Heer,et al.  Gender differences in acute non-ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.

[23]  E. Toft,et al.  Comparison of degrees of left ventricular dilation within three hours and up to six days after onset of first acute myocardial infarction. , 1997, The American journal of cardiology.

[24]  Karl Swedberg,et al.  Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. , 2004, European heart journal.

[25]  C. Viscoli,et al.  Differences between women and men in survival after myocardial infarction. Biology or methodology , 1990 .

[26]  L. Køber,et al.  Different prognostic impact of systolic function in patients with heart failure and/or acute myocardial infarction , 2005, European journal of heart failure.

[27]  The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population. The Trace Study Group. , 1994, The American journal of cardiology.

[28]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .